Johnson & Johnson completed the previously unheralded acquisition of privately held Laminar Inc. for $400 million upfront, with undisclosed contingent payments depending on achievement of clinical and regulatory milestones starting in 2024. The deal provides the med-tech giant a potentially game-changing entree into the lucrative left atrial appendage (LAA) market.
Johnson & Johnson said Thursday that its medical technology segment has acquired medical device maker Laminar Inc. in a deal that will reduce its full-year.
Innovative investigational device designed for Left Atrial Appendage Elimination to reduce the risk of stroke in patients with non-valvular atrial fibrillation
Strengthens position in high-growth.
Johnson & Johnson MedTech Completes Laminar Acquisition, Sees $0.15/share Negative Impact In FY24 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson MedTech (JNJ) Acquires Laminar, Inc. for $400 Million Plus Milestone Payments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.